GlycanAge, a biotech startup pioneering the field of glycan biomarkers, announced the successful completion of its €3.9 million seed funding round, led by LAUNCHub Ventures and UK-based deep-tech fund Kadmos Capital. This marks a substantial leap forward in the company’s quest to redefine personalized preventative healthcare. The field of glycobiology, despite its potential, has historically…
This content is for members only. Visit the site and log in/register to read.
The post Croatian longevity startup GlycanAge secures €3.9 million to advance personalized preventative care appeared first on EU-Startups.